These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6399968)

  • 1. Analysis of R factors in Serratia marcescens strains isolated from the "Hospital Universitario de Caracas".
    Rodríguez Lemoine V; de Ramírez Y; Pedroza R
    Acta Cient Venez; 1983; 34(3-4):228-32. PubMed ID: 6399968
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serratia marcescens ("B. prodigiosus"), the germ of hospital infections].
    Modde H
    Rev Med Suisse Romande; 1974 Apr; 94(4):325-32. PubMed ID: 4596928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R-plasmids carried by nosocomial strains of Serratia marcescens: host range and stability.
    Mendez FJ; Mendoza MC; Llaneza J; Hardisson C
    Microbiol Esp; 1984; 37(1-2):1-8. PubMed ID: 6399093
    [No Abstract]   [Full Text] [Related]  

  • 5. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo effect of ciprofloxacin on plasmid-mediated resistance.
    Mehtar S; Blakemore PH; Ellis K
    Chemioterapia; 1987 Jun; 6(2 Suppl):210-1. PubMed ID: 3334559
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular epidemiology of Serratia marcescens in a hospital.
    Sekiguchi J; Fujino T; Kuroda E; Konosaki H; Nishimura H; Saruta K; Kawana A; Yamanishi F; Kudo K; Kondo T; Yazaki Y; Kuratsuji T; Kirikae T
    Jpn J Infect Dis; 2004 Apr; 57(2):78-80. PubMed ID: 15118217
    [No Abstract]   [Full Text] [Related]  

  • 8. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R factors from Serratia marcescens.
    Hedges RW; Rodriguez-Lemoine V; Datta N
    J Gen Microbiol; 1975 Jan; 86(1):88-92. PubMed ID: 1089756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifactorial origin of high incidence of Serratia marcescens in a cardio-thoracic ICU: analysis of risk factors and epidemiological characteristics.
    de Boer MG; Brunsveld-Reinders AH; Salomons EM; Dijkshoorn L; Bernards AT; van den Berg PC; van den Broek PJ
    J Infect; 2008 Jun; 56(6):446-53. PubMed ID: 18511122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of eight aminoglycosides against isolates of Serratia marcescens from four hospitals.
    Verbist L; Vandepitte J; Vandeven J
    J Antimicrob Chemother; 1978 Jan; 4(1):47-55. PubMed ID: 342482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Uropathogenic Serratia marcescens of hospital origin: analysis of the adhesion mechanism of 2 strains].
    Padilla C; Brevis P; Padilla R
    Rev Med Chil; 1989 Jun; 117(6):629-35. PubMed ID: 2519411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.
    Schaefler S; Winter J; Catelli A; Greene J; Toharski B
    Appl Microbiol; 1971 Sep; 22(3):339-43. PubMed ID: 4940874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.